|
|
Article: Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals.
- Article from:
- Business Wire
- Article date:
- June 30, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
-Maxygen to Contribute R&D Operations and Assets to Newly-Formed Joint Venture-
-Astellas to be Granted 3-Year Option to Acquire Joint Venture-
-Maxygen Plans Strategic Restructuring of Remaining Operations-
-Maxygen to Host Conference Call on July 1, 2009 at 4:30 p.m. ET (1:30 p.m. PT)-
REDWOOD CITY, Calif. -- Maxygen, Inc. (Nasdaq:MAXY) today announced that Astellas Pharma Inc. and Maxygen have executed an agreement to establish a joint venture focused on the discovery, research and development of multiple protein pharmaceutical programs, including Maxygen's MAXY-4 program and other early stage programs. As part of the arrangement, ...